Less scrupulous companies are distributing and selling retatrutide and other unregulated peptides, often produced in China, to people all around the world
Important clinical considerations include: The metabolic changes generally track with body weight
This pricing transparency removes barriers to safe dose optimization, particularly for patients managing multiple chronic conditions like opioid use disorder and obesity simultaneously
Smaller portions are easier to digest and produce less fermentation
Some researchers are investigating whether semaglutide affects how blood clots form, but so far, there is no strong evidence linking the medication to a higher risk of clotting
A retrospective analysis of the DURATION trials found that overall, greater weight loss was associated with gastrointestinal adverse events with exenatide once weekly and exenatide twice daily